Cognition Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 1.24 M | $582,758 | 8.28% | 3.07% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 500,000 | $234,300 | 0.00% | 1.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 323,643 | $151,680 | 32.22% | 0.80% |
| CM MANAGEMENT, LLC | 11/12/2024 | 250,000 | $117,150 | 25.00% | 0.62% |
| AMERICAN FINANCIAL GROUP INC | 11/12/2024 | 205,000 | $96,000 | 0.00% | 0.51% |
| UBS GROUP AG | 11/14/2024 | 197,859 | $92,796 | 100.00% | 0.49% |
| SIGMA PLANNING CORP | 11/04/2024 | 197,190 | $92,403 | 14.55% | 0.49% |
| KESTRA ADVISORY SERVICES, LLC | 11/13/2024 | 188,434 | $88,300 | 0.00% | 0.47% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 155,545 | $72,888 | 100.00% | 0.38% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 140,943 | $64,000 | 100.00% | 0.35% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 90,665 | $42,000 | 0.00% | 0.22% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 88,700 | $41,565 | -1.13% | 0.22% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 76,700 | $35,942 | 0.00% | 0.19% |
| STATE STREET CORP | 11/14/2024 | 62,750 | $29,405 | 0.00% | 0.16% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 57,231 | $27,000 | 100.00% | 0.14% |
| TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | 11/14/2024 | 55,395 | $25,958 | 0.00% | 0.14% |
| FCA CORP /TX | 11/13/2024 | 51,471 | $24,119 | 0.00% | 0.13% |
| CIRCLE WEALTH MANAGEMENT, LLC | 11/14/2024 | 48,842 | $22,888 | 0.00% | 0.12% |
| CASTLE WEALTH MANAGEMENT LLC | 10/31/2024 | 43,380 | $20,328 | 0.00% | 0.11% |
| BANGOR SAVINGS BANK | 10/07/2024 | 34,019 | $15,941 | 0.00% | 0.08% |
| NORTHEAST FINANCIAL CONSULTANTS INC | 11/15/2024 | 24,500 | $11,481 | 0.00% | 0.06% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11/08/2024 | 23,500 | $11,012 | -41.25% | 0.06% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 22,962 | $11,000 | 0.00% | 0.06% |
| JANE STREET GROUP, LLC | 11/15/2024 | 22,730 | $10,652 | 100.00% | 0.06% |
| MERCER GLOBAL ADVISORS INC /ADV | 11/14/2024 | 16,051 | $7,066 | -83.27% | 0.04% |
| BESSEMER GROUP INC | 11/12/2024 | 13,797 | $6,000 | 100.00% | 0.03% |
| SMITH ANGLIN FINANCIAL, LLC | 10/07/2024 | 12,000 | $5,623 | 0.00% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 11,370 | $5,328 | 100.00% | 0.03% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 11,000 | $5,155 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 10,990 | $5,154 | 3.38% | 0.03% |
| RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 10,000 | $4,686 | 0.00% | 0.02% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 5,867 | $2,749 | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 5,279 | $2,471 | 1.17% | 0.01% |
| BRAY CAPITAL ADVISORS | 11/01/2024 | 2,250 | $1,054 | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,800 | $846 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 1,000 | $469 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 1,000 | $469 | -66.67% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 78 | $37 | 100.00% | 0.00% |
| FMR LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CARLSON CAPITAL L P | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 11/07/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SANDY SPRING BANK | 10/25/2024 | 0 | $0 | -100.00% | 0.00% |
| AWM INVESTMENT COMPANY, INC. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BAIRD FINANCIAL GROUP, INC. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Cognition Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 59 institutional investors and hedge funds held shares of Cognition Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.24 M
Alyeska Investment Group, L.P.: 500,000
GEODE CAPITAL MANAGEMENT, LLC: 323,643
CM Management, LLC: 250,000
AMERICAN FINANCIAL GROUP INC: 205,000
UBS Group AG: 197,859
10.52% of Cognition Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.69 M shares in the last 24 months. This purchase volume represents approximately $5.15 M in transactions.